🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
No therapeutic agent is currently approved for the treatment of SARSCoV-2 i...
Status
Unknown
Location
DHR Health Institute for Research and Development
Start Date
2020-11-20
Trial ID
NCT04840459
Treatments Being Tested
The purpose of this study is to evaluate whether LY3819253 given alone and ...
Status
Completed
Location
Unv of AL Sch of Med Div of Infectious Diseases
Start Date
2020-08-02
Trial ID
NCT04497987
Treatments Being Tested
Absence of anti-SARS-CoV-2 vaccine response or insufficient vaccine respons...
Status
Completed
Location
Assistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospital
Start Date
2021-08-01
Trial ID
NCT05439044
Treatments Being Tested
The human immune system is designed to protect individuals from external so...
Status
Recruiting
Location
All Natural Medicine Clinic, LLC
Start Date
2025-01-01
Trial ID
NCT04790240
Treatments Being Tested
COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2...
Status
Terminated
Location
University of Calgary
Start Date
2021-02-12
Trial ID
NCT04748588
Treatments Being Tested
The purpose of this study is to test the safety and tolerability of LY38192...
Status
Completed
Location
Cedars Sinai Medical Center
Start Date
2020-05-28
Trial ID
NCT04411628
The purpose of this study is to find out whether bamlanivimab is able to st...
Status
Completed
Location
Presbyterian Medical Center
Start Date
2021-02-01
Trial ID
NCT04701658
Treatments Being Tested
The purpose of this research is to test whether a new medication called bam...
Status
Unknown
Location
Fraser Health Authority
Start Date
2021-03-17
Trial ID
NCT04796402
Treatments Being Tested
The purpose of this study is to measure how well LY3819253 and LY3832479 wo...
Status
Completed
Location
Clinnova Research - Redondo Beach
Start Date
2020-06-17
Trial ID
NCT04427501
The purpose of this study is to measure how well monoclonal antibodies work...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-10-29
Trial ID
NCT04634409
Treatments Being Tested